Nucleic acids from bacteria or viruses induce potent immune responses in infected cells 1,2 . Cyclic dinucleotides such as c-di-GMP and cyclic diadenylate monophosphate are immune stimulators that regulate the induction of type I interferons (IFN-α and IFN-β) 3-5 . These special nucleotides are secondary messenger molecules that regulate bacterial motility, biofilm formation and virulence-gene expression 6,7 . STING, a protein localized on the endoplasmic reticulum membrane, is an innate immune sensor of cyclic dinucleotides 8 . STING is also critical in the innate immune response toward microbial DNA and RNA 9,10 . Two putative DNA sensors, IFI16 and DDX41, stimulate the induction of type I interferons in a STING-dependent manner 11,12 . Stimulation of cells by double-stranded DNA induces the recruitment of the protein kinase TBK1 and the transcription factor IRF3 to STING 13 . The proximity of TBK1 and IRF3 facilitates phosphorylation of IRF3, leading to its dimerization and translocation to the nucleus to activate IFN-β gene transcription. The molecular structure of STING bound to a cyclic dinucleotide will help elucidate the mechanism of STING activation.
Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system 
STING (stimulator of interferon genes) is an innate immune sensor of cyclic dinucleotides that regulates the induction of type I interferons. STING's C-terminal domain forms a V-shaped dimer and binds a cyclic diguanylate monophosphate (c-di-GMP) at the dimer interface by both direct and solvent-mediated hydrogen bonds. Guanines of c-di-GMP stack against the phenolic rings of a conserved tyrosine, and mutations at the c-di-GMP binding surface reduce nucleotide binding and affect signaling.
Nucleic acids from bacteria or viruses induce potent immune responses in infected cells 1, 2 . Cyclic dinucleotides such as c-di-GMP and cyclic diadenylate monophosphate are immune stimulators that regulate the induction of type I interferons (IFN-α and IFN-β) [3] [4] [5] . These special nucleotides are secondary messenger molecules that regulate bacterial motility, biofilm formation and virulence-gene expression 6, 7 . STING, a protein localized on the endoplasmic reticulum membrane, is an innate immune sensor of cyclic dinucleotides 8 . STING is also critical in the innate immune response toward microbial DNA and RNA 9, 10 . Two putative DNA sensors, IFI16 and DDX41, stimulate the induction of type I interferons in a STING-dependent manner 11, 12 . Stimulation of cells by double-stranded DNA induces the recruitment of the protein kinase TBK1 and the transcription factor IRF3 to STING 13 . The proximity of TBK1 and IRF3 facilitates phosphorylation of IRF3, leading to its dimerization and translocation to the nucleus to activate IFN-β gene transcription. The molecular structure of STING bound to a cyclic dinucleotide will help elucidate the mechanism of STING activation.
We have conducted systematic screening of mouse and human STING constructs and identified a fragment of the human STING C-terminal domain (CTD) containing residues 155-341, which is soluble and can be crystallized. Gel-filtration chromatography showed that the STING CTD forms a dimer in solution ( Fig. 1a) . Isothermal titration calorimetry (ITC) showed that the STING CTD binds c-di-GMP with an affinity (K d ) of ~5 µM (Fig. 1b) . Two STING molecules bind one c-di-GMP, indicating that a STING dimer shares one c-di-GMP binding site. The binding interaction is enthalpy driven (∆H = -14.5 kcal mol −1 , ∆S = -24.3 cal mol −1 K −1 ). A slightly larger STING construct containing residues 155-379 has a similar affinity (K d ~2.4 µM) for c-di-GMP, demonstrating that truncation of the 38 C-terminal residues does not affect c-di-GMP binding (Fig. 1c) .
To elucidate the structural basis of cyclic dinucleotide recognition by STING, we have determined the structure of human STING CTD bound to c-di-GMP at 1.5 Å resolution ( Fig. 1d, Supplementary  Table 1 ). The crystallographic asymmetric unit contains a STING dimer in complex with a c-di-GMP molecule. The STING dimer has a V-shaped structure, and the c-di-GMP binding site is located at the bottom of the V of the dimer interface. The c-di-GMP also adopts a V-shaped conformation ( Fig. 1d, Supplementary Fig. 1a ), and it contacts the STING dimer through stacking of both guanine bases against the phenolic rings of Tyr167 ( Supplementary Fig. 1b ).
Residues 228-236 in the loop connecting strands β3 and β4 of STING are not well defined in the electron-density map, likely because of the flexibility of this loop. This loop harbors a potential TRAF2 binding motif, PQQTGD 14 , and may play a role in signaling by STING.
The STING CTD exhibits a novel α/β-type fold ( Fig. 1d ) with some structural similarity to the Ras family of small G proteins 15 . It contains a central five-stranded β-sheet sandwiched between four α-helices. The first α-helix of STING, containing residues 155-174, is rich in hydrophobic residues and was previously predicted to be a transmembrane helix 16 . This helix is long and bent in the middle at residues Gly166 and Pro173. Helices α1 and α2 mediate dimer formation and harbor key residues for c-di-GMP binding. Truncation of helix α1 makes the protein insoluble, indicating that helix α1 is an integral part of STING's nucleotide binding domain and is required for proper folding of the protein.
The total buried surface area between the c-di-GMP and STING is ~1,100 Å 2 . The interaction between c-di-GMP and STING is by both direct and solvent-mediated hydrogen bonds ( Fig. 2a) . The interactions between the two STING molecules and the c-di-GMP are similar, and therefore only half of the c-di-GMP interactions with STING will be described. The guanine base of c-di-GMP forms only one direct hydrogen bond with the hydroxyl group of Thr263 ( Fig. 2a) . It also forms two solvent-mediated hydrogen bonds with the backbone amine and carbonyl of Ser241 ( Fig. 2a) . In addition, the guanine forms a solventmediated hydrogen bond with the side chain hydroxyl of Tyr163 and the carbonyl of Tyr261 ( Fig. 2a ). Glu260 plays a critical role in forming the c-di-GMP binding site by interacting with the side chain of Tyr167 through direct hydrogen bonds so that the phenolic ring of Tyr167 can be positioned properly to stack against the guanine base ( Fig. 2a) . The side chain of Asn242 forms a network of hydrogen bonds with Glu260, Tyr167 and Arg178. These interactions are important for orienting Ser241 and Tyr167 to interact with the guanine base. The 2′ hydroxyl of the ribose interacts directly with the hydroxyl of Thr263 (Fig. 2a) . The hydroxyl of Thr267 forms two solvent-mediated hydrogen bonds with the ribose and the phosphate group ( Fig. 2a) . In addition, the phosphate group interacts with the backbone carbonyl of Gly166 through a b r i e F c o m m u n i c at i o n s solvent-mediated hydrogen bond. Other STING residues are also critical for c-di-GMP binding. For example, Pro264 is critical in the formation of the binding surface because it helps position Thr263 and Thr267 to interact with c-di-GMP. Gly166 is also critical for c-di-GMP binding, allowing the nucleotide to approach its binding surface closely and thus permitting the stacking of the guanine ring on the phenolic ring of Tyr167. Although Ser162 does not interact with c-di-GMP directly, together with Thr267 and several ordered solvent molecules it forms a large, flat, hydrophilic cushion to accommodate the ribose and phosphate ring of c-di-GMP.
The total buried surface area at the STING dimer interface is ~1,550 Å 2 . The two monomers interact with each other through extensive hydrophobic interactions involving residues Val155, Leu157, Trp161 and Ile165 in helix α1 and Ala270, Met271 and Ala277 near the linker region between helices α2 and α3 (Fig. 2b) . In addition, there are two direct hydrogen bonds between the side chain phenolic groups of Tyr164 and Tyr274 (Fig. 2b) . Residues at the N terminus of helix α1 are critical for the formation of the dimer, explaining why truncation of this helix resulted in insoluble protein.
Two calcium ions are observed between two crystallographic symmetry-related STING dimers (Fig. 2c) . The calcium-binding site is located at the loop between strand β1 and β2 and the loop between strand β5 and helix α4 (Fig. 2c) . The side chains of Glu316 and Asp320 from one STING molecule, the carbonyl of Ala318 and the side chain of Asp205 from a symmetry-related STING molecule, and two water molecules coordinate with each of the calcium ions, in octahedral geometry (Fig. 2d) . Mutations of mouse STING at Glu315 (which corresponds to the calcium ligand Glu316 in human STING) to either alanine, asparagine or glutamine made mouse STING hyperactive and spontaneously induced interferon expression even at low levels of transfection 8 . These mutants also failed to respond to c-di-GMP. Mutation of another calcium ligand, Asp204, to alanine also increased mouse STING signaling, although it failed to respond to c-di-GMP 8 . These results indicate that calcium plays a critical role in regulating STING function.
To investigate the potential conformational change induced by c-di-GMP binding, we have determined the structure of ligand-free STING CTD at 1.9-Å resolution. Superposition of the ligand-free STING structure over the c-di-GMP complex structure showed minor differences between the two structures (r.m.s. deviation of ~0.5 Å, Supplementary  Fig. 2) . As ligand-free STING crystallized in nearly the same unit cell as the c-di-GMP complex, it is likely that crystal packing contributes to the similar structures. These results suggest that the c-di-GMP binding site of STING is likely preformed and that the dimer is rigid.
Based on the structure of STING bound to c-di-GMP, we designed 11 mutants of human STING and studied their binding with c-di-GMP by gel-filtration chromatography and ITC. Three of the 11 mutants, Y163A, Y167A and I200N, failed to be expressed as soluble proteins. Mutations G166S or S162A reduced c-di-GMP binding slightly (Fig. 3a,b) . T263A reduced the c-di-GMP binding affinities to 17 and 10 µM, respectively (Fig. 3b) . Mutants N242A and E260A had severely reduced c-di-GMP binding (Fig. 3a,b) . Mutations of T263A and Pro264A also reduced c-di-GMP binding (Fig. 3a,b) . In addition, mutation T267A reduced c-di-GMP binding affinity by a factor of almost 7 (Fig. 3b) .
Because human STING is not sensitive to c-di-GMP when expressed in HEK293T cells, we established an IFN-β luciferase reporter assay for mouse STING that responds to c-di-GMP (Supplementary Fig. 3a) . Mutations in mouse STING that correspond to the human STING residues involved in c-di-GMP binding were examined using the assay (Fig. 3c) . Consistent with previous studies 8 , mutant I199N was not expressed well and failed to respond to c-di-GMP ( Fig. 3c, Supplementary Fig. 3b ). Although the remaining six mutants were normally expressed ( Supplementary Fig. 3b) , mutants Y239S and E259A also failed to respond to c-di-GMP (Fig. 3c) . In addition, mutant T262A exhibited reduced response to c-di-GMP ( Fig. 3c) . Notably, mutations N241A, P263A and T266A enabled the mouse STING to be hyperactive even in the absence of c-di-GMP ( Fig. 3c) , but only mutant P263A retained some response to c-di-GMP. STING is potently phosphorylated by TBK1 at the C terminus ( Supplementary Fig. 4a ). Phosphorylation of STING truncated after residue 341 is significantly reduced (Supplementary Fig. 4a) . The time course of the phosphorylation experiments showed that STING dephosphorylated after 30 min at 1 mM ATP (Supplementary Fig. 4b ) and that phosphatase inhibitors reduced the dephosphorylation of STING (Supplementary Fig. 4c ). Phosphorylation assays with 5 mM ATP resulted in persistent phosphorylation of STING ( Supplementary  Fig. 4b ). We also tested the effects of STING and c-di-GMP on IRF3 activation by TBK1, using purified proteins. The rates of TBK1-dependent phosphorylation and dimerization of IRF3 were not affected by human STING (containing residues 155-379) or human STING in complex with c-di-GMP (Supplementary Fig. 5a) . Similar results were observed with mouse STING (Supplementary Fig. 5b) .
The high-resolution structure of STING bound to c-di-GMP provides a detailed picture of how the protein recognizes the cyclic dinucleotide. Similar structural observations have recently been published 17 . However, it is still not clear how c-di-GMP activates the TBK1-IRF3 signaling pathway. Although STING can recruit TBK1 and IRF3 through its C-terminal region and may facilitate the TBK1dependent phosphorylation of IRF3 in cells stimulated with DNA 13 , whether c-di-GMP uses a similar mechanism to activate IRF3 awaits further analysis. Our in vitro assays showed that STING is phosphorylated by TBK1. However, the STING CTD alone or in combination with c-di-GMP failed to stimulate the TBK1-dependent phosphorylation and dimerization of IRF3. These results suggest that other proteins or membrane localization of STING are likely needed for the activation of IRF3 by c-di-GMP. Indeed, the inclusion of cell lysate from DNA-stimulated cells resulted in IRF3 phosphorylation by TBK1 in the presence of STING 13 . Affinity purification of proteins associated with STING in vivo may reveal additional factors necessary for cyclic dinucleotide sensing. Biochemical and structural characterization of these proteins will provide additional insight into the roles of STING in innate immune responses to nucleic acids.
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